SCHEMBL9008970

SCHEMBL9008970

Fc1cc(OCc2ccccc2)cc(-c2ccncc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.48
CYP17A1 P05093 1/20 0.48
CYP21A2 P08686 1/20 0.48
F2 P00734 2/20 0.47
KCNH2 Q12809 1/20 0.47
GRIN2B Q13224 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
FFAR1 O14842 1/20 0.45
CYP11B2 P19099 2/20 0.45
GSTP1 P09211 2/20 0.44
NOX1 Q9Y5S8 1/20 0.44
PDE4B Q07343 1/20 0.42
CYP19A1 P11511 1/20 0.42
IKBKB O14920 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PRMT5 O14744 1/20 0.42
MAPK13 O15264 1/20 0.42
MAPK12 P53778 1/20 0.42
MAPK11 Q15759 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31160636 0.81 MEN1 (0.59) SMN1; SMN2FFAR1GSTP1MEN1KMT2A
SCHEMBL5042093 0.81 ALOX5 (0.55) SMN1; SMN2FFAR1GSTP1CYP19A1MEN1
SCHEMBL1956583 0.80 MRGPRX4 (0.58) PDE4BROCK2GRK2
SCHEMBL1957932 0.79 F2 (0.62) F2KCNH2GRIN2BSMN1; SMN2FFAR1
Tert-Butyl Formate SCHEMBL27828076 0.76 GSTP1 (0.43) FFAR1GSTP1CYP19A1MEN1KMT2A
SCHEMBL953509 0.75 F2 (0.65) F2KCNH2GRIN2BSMN1; SMN2ALOX5
SCHEMBL16886123 0.74 CYP1A2 (0.58) FFAR1CYP19A1MEN1KMT2AALOX5
SCHEMBL31183087 0.74 CYP1A2 (0.58) FFAR1CYP19A1MEN1KMT2AALOX5
SCHEMBL17137714 0.74 IP6K1 (0.44) FFAR1GSTP1PRMT5
SCHEMBL3565011 0.73 LTB4R (0.53) FFAR1GSTP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576338-A ANTIALLERGENS, ANTIHISTAMINES, ANTIINFLAMMATORY AGENTS AND CYTOPROTECTIVE AGENTS FOR CARDIOVASCULAR DISORDERS MERCK FROSST CANADA, INC. (CA) 1996-11-19 US disclosed